The expression of the c-kit receptor by epidermal melanocytes may be reduced in vitiligo

British Journal of Dermatology

Volumn 134, Issue 2, 1996, Pages 299-306

  Norris, A ^a   Todd, C ^a   Graham, A ^a   Quinn, A G ^a   Thody, A J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE; TYROSINE KINASE RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; MELANOCYTE; PRIORITY JOURNAL; VITILIGO;

EID: 0030021883     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb07618.x     Document Type: Article

References (26)

1. Naughton GK, Eisinger M, Bystryn JC. Antibodies to normal melanocytes in vitiligo. J Exp Med 1983; 158: 246-51.
2. Cui J, Arita Y, Bystryn JC. Cytolytic antibodies to melanocytes in vitiligo. J Invest Dermatol 1993; 100: 812-15.
3. Lerner AB. On the etiology of vitiligo and gray hair. Am J Med 1971; 51: 141-7.
4. Moellman G, Klein-Agarer S, Schollay DA et al. Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo. J Invest Dermatol 1982; 79: 321-30.
5. Bhawan J, Bhutani LK. Keratinocyte damage in vitiligo. J Cutan Pathol 1983; 10: 207-12.
6. Yu HS, Kao CH, Yu CL. Co-existence and relationship of antikeratinocyte and antimelanocyte antibodies in patients with non-segmental-type vitiligo. J Invest Dermatol 1993; 100: 823-8.
7. De Luca M, D'Anna F, Bondanza S et al. Human epithelial cells induce melanocyte growth in vitro but only skin keratinocytes regulate its proper differentiation in the absence of dermis. J Cell Biol 1988; 107: 1919-26.
8. Donatien P, Surlève-Bazeille JE, Thody AJ, Taïeb A. Growth and differentiation of normal human melanocytes in a TPA free, cholera toxin free, low serum medium and keratinocyte influence. Arch Dermatol Res 1993; 285: 385-92.
9. Puri N, Mojamdar M, Ramaiah A. In vitro growth characteristics of melanocytes obtained from adult normal and vitiligo subjects. J Invest Dermatol 1987; 88: 434-8.
10. Ramaiah A, Puri N, Mojamdar M. Etiology of vitiligo. A new hypothesis. Acta Derm Venereol (Stockh) 1989; 69: 323-67.
11. Medrano EE, Nordlund JJ. Successful culture of adult human melanocytes obtained from normal and vitiligo donors. J Invest Dermatol 1990; 95: 441-5.
12. Halaban R, Ghosh S, Baird A. bFGF is the putative natural growth factor for human melanocytes. In vitro Cell Dev Biol 1987; 23: 47-52.
13. Halaban R, Rubin JS, Funasaka Y et al. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogene 1992; 7: 2195-206.
14. Funasaka Y, Boulton T, Cobb M et al. c-kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas. Mol Biol Cell 1992; 3: 197-209.
15. Jackson IJ. Mouse coat colour mutations: a molecular genetic resource which spans the centuries. Bio Essays 1991; 13: 439-46.
16. Fleischmann R. From white spots to stem cells: the role of the kit receptor in mammalian development. Trends Genet 1993; 9: 285-90.
17. Fleischman RA, Saltman DL, Stastny V, Zneimer S. Deletion of the c-kit protooncogene in the human developmental defect piebald trait. Proc Natl Acad Sci USA 1991; 88: 10885-9.
18. Giebel LD, Spritz RA. Mutation of the kit (mast/stem cell growth factor receptor) protooncogene in human piebaldism. Proc Natl Acad Sci USA 1991; 88: 8696-9.
19. Shu SY, Ju G, Fan LZ. The glucose oxidase - DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci Lett 1988; 85: 169-71.
20. Thomson TM, Mattes MJ, Roux L et al. Pigmentation-associated glycoprotein of human melanomas and melanocytes: definition with a mouse monoclonal antibody. J Invest Dermatol 1985; 85: 169-74.
21. Le Poole IC, van den Wijngaard RMJGF, Westerhof W et al. Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol 1993; 100: 816-22.
22. Dippel E, Haas N, Grabbe J et al. Expression of c-kit receptor in hypomelanosis: a comparative study between piebaldism, naevus depigmentosus and vitiligo. Br J Dermatol 1995; 132: 182-9.
23. Isozaki K, Tsujimura T, Nomura S et al. Cell type-specific deficiency of c-kit gene expression in mutant mice of mi/mi genotype. Am J Pathol 1994; 145: 827-36.
24. Hodgkinson CA, Moore KJ, Nakayama A et al. Mutations and the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 1993; 74: 395-404.
25. Lerner AB, Shibara T, Boissy RE et al. A mouse model for vitiligo. J Invest Dermatol 1986; 87: 299-304.
26. Steel KP, Davidson DR, Jackson IJ. TRP-2/DT, a new early melanoblast marker, shows that steel growth factor (c-kit ligand) is a survival factor. Development 1992; 115: 1111-19.